Ankle Fracture Tourniquet Utilization
Launched by ALEX DEMERS · Mar 6, 2025
Trial Information
Current as of July 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Lower extremity tourniquet utilization remains a controversial practice during the operative fixation of rotational ankle fractures and is often left to surgeon discretion. At our own institution, tourniquet use varies between surgeons with some providers using a tourniquet for every case, while others regularly do not utilize tourniquets. Despite benefits of decreased surgical time and decreased blood loss, many studies have cited negative outcomes associated with tourniquet usage including increased postoperative swelling and pain, increased wound complications, and increased risks of dee...
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • 1. Patients \>18 y.o. undergoing ankle fracture open reduction internal fixation
- • 2. Ground level fall as mechanism of injury
- • 3. Closed injury
- Exclusion criteria:
- • 1. Open Ankle Fractures
- • 2. Vascular Injury Requiring Intervention
- • 3. Lower extremity injuries on same side of ankle fracture
- • e) Active anticoagulation/bleeding disorder necessitating tourniquet use (Hemoglobin \<7, PT \>13, PTT\>35) f) Ipsilateral lower extremity trauma impacting immobilization g) Patients with peripheral neuropathy h) Patients undergoing ankle arthroscopy
About Alex Demers
Alex Demers is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapies and cutting-edge technologies, Alex Demers collaborates with leading healthcare professionals and institutions to design and execute rigorous clinical studies. By prioritizing ethical standards and patient safety, Alex Demers aims to facilitate the development of effective treatments that address unmet medical needs. Through meticulous planning and execution, the organization strives to contribute valuable insights to the scientific community and enhance the quality of care for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Iowa City, Iowa, United States
Patients applied
Trial Officials
Alex Demers, MD
Principal Investigator
University of Iowa
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported